Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Multiple Sclerosis
100%
Progressive multiple Sclerosis
12%
Diffusion Tensor Imaging
11%
Magnetic Resonance Imaging
11%
Multiple Sclerosis Treatment
11%
Relapsing-remitting multiple Sclerosis
11%
Radial Diffusivity
10%
Disability
10%
Neuromyelitis Optica
9%
Optic Neuritis
9%
Phase II Trial
8%
Diffusion Basis Spectrum Imaging
8%
Dimethyl Fumarate
8%
Ibudilast
7%
Cerebrospinal Fluid
7%
Optic Nerve
6%
Diroximel Fumarate
6%
Disease-modifying Therapy
6%
Demyelination
6%
Placebo
5%
Healthcare Solutions
5%
Advanced Technologies
5%
Optical Coherence Tomography
5%
Confidence Interval
5%
Spinal Cord
5%
Randomized Double-blind
5%
Technology Solutions
5%
Brain Atrophy
5%
Neuroscience
Multiple Sclerosis
88%
Magnetic Resonance Imaging
12%
Diffusion Tensor Imaging
11%
Magnetic Resonance Imaging
9%
Neuromyelitis Optica
9%
Optic Neuritis
9%
Placebo
7%
Optic Nerve
6%
Ibudilast
5%